Pharmaceutical research and development (R&D) organizations were early adopters who recognized the many benefits of UltraPerformance LC? (UPLC?) Technology including resolution, sensitivity, throughput, and productivity as compared to HPLC.
Peter Alden
Advertisement
Articles by Peter Alden
This article aims to demonstrate a novel accelerated method development approach to develop HPLC and/or UPLC methods
Advertisement
Latest Updated Articles
Implementation of Methods Translation between Liquid Chromatography InstrumentationPublished: October 1st 2010 | Updated:
An Automated Workflow for Accelerated Development of a Robust LC Method within a QbD FrameworkPublished: May 24th 2010 | Updated:
Advertisement
Advertisement
Trending on LCGC International
1
Navigating Adverse Reactions in GLP-1 Treatment
2
Decoding Sweet Potato Drought Resilience: Metabolomic Evidence from UPLC-MS Profiling
3
Toward Safer Diabetes Devices: GC–MS Detection of Allergens in Sensors, Pumps, and Infusion Sets
4
Advancing RNA-Based Therapeutics: IQ Consortium Experts on Optimizing Chromatographic Bioanalysis
5
